Syed Iqbal H, Balakrishnan P, Murugavel K G, Suniti Solomon
YRG Centre for AIDS Research and Education (YRG CARE), Voluntary Health Services Hospital Campus, Chennai, India.
J Clin Lab Anal. 2008;22(3):178-85. doi: 10.1002/jcla.20238.
Diagnostic kits for the detection of human immunodeficiency virus (HIV) antibodies have reached an unprecedented number. But choice of an ideal, cost-effective, and rapid test for HIV infection is of immense value for use in developing countries like India, where resources are limited. In this study we have evaluated the performance characteristics of the rapid immunochromatographic HIV test kit First Response HIV 1-2.O. First, the laboratory archived 450 characterized plasma/serum specimens, which were tested on First Response HIV 1-2.O. Second, a total of 134 consecutive voluntary counseling and testing (VCT) specimens were also tested and positive specimens were further confirmed with HIV TRI-DOT. All these VCT specimens were cross-checked with HIV double-enzyme-linked immunosorbent assay (ELISA) (Murex and Vironostika), and the results were matched. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and efficiency of First Response HIV 1-2.O with the 450 characterized specimens was 100% for HIV-1 with reference assay. The results in the VCT algorithm were correlating with double-ELISA. In the HIV-2 analysis, five HIV-2-positive specimens in First Response HIV 1-2.O were found to be HIV-2-indeterminate on Western blot. HIV TRI-DOT was unable to pick up two HIV-2 Western blot-positive specimens. First Response HIV 1-2.O has several advantages: low-cost (U.S. $0.70); only 10 microL of specimen; involves only two steps; room temperature storage; ability to differentiate HIV-1 and 2; and use of whole blood specimen. Hence this test kit could be suitable for initial screening in the HIV testing algorithm in resource-limited settings. J. Clin. Lab. Anal. 22:178-185, 2008. (c) 2008 Wiley-Liss, Inc.
用于检测人类免疫缺陷病毒(HIV)抗体的诊断试剂盒数量已达到前所未有的程度。但对于像印度这样资源有限的发展中国家而言,选择一种理想、经济高效且快速的HIV感染检测方法具有巨大价值。在本研究中,我们评估了快速免疫层析HIV检测试剂盒First Response HIV 1-2.O的性能特征。首先,实验室存档了450份已鉴定的血浆/血清标本,并使用First Response HIV 1-2.O进行检测。其次,共检测了134份连续的自愿咨询检测(VCT)标本,阳性标本进一步通过HIV TRI-DOT进行确认。所有这些VCT标本均与HIV双酶联免疫吸附测定(ELISA)(Murex和Vironostika)进行交叉核对,结果相符。对于450份已鉴定标本,First Response HIV 1-2.O检测HIV-1的灵敏度、特异性、阳性预测值(PPV)、阴性预测值(NPV)和效率与参考检测方法相比均为100%。VCT检测流程中的结果与双ELISA相关。在HIV-2分析中,First Response HIV 1-2.O检测出的5份HIV-2阳性标本经蛋白质印迹法检测为HIV-2不确定。HIV TRI-DOT未能检测出2份蛋白质印迹法检测为HIV-2阳性的标本。First Response HIV 1-2.O具有多个优点:成本低(0.70美元);仅需10微升标本;仅涉及两个步骤;可在室温下保存;能够区分HIV-1和HIV-2;可使用全血标本。因此,该检测试剂盒可能适用于资源有限环境下HIV检测流程中的初步筛查。《临床实验室分析杂志》2008年第22卷:178 - 185页。(c)2008威利 - 利斯公司